Compare HALO & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | UGI |
|---|---|---|
| Founded | 1998 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4B | 8.1B |
| IPO Year | N/A | N/A |
| Metric | HALO | UGI |
|---|---|---|
| Price | $62.22 | $38.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 1 |
| Target Price | ★ $73.33 | $39.00 |
| AVG Volume (30 Days) | ★ 2.5M | 2.4M |
| Earning Date | 11-03-2025 | 11-20-2025 |
| Dividend Yield | N/A | ★ 3.93% |
| EPS Growth | 56.68 | ★ 147.20 |
| EPS | ★ 4.74 | 3.09 |
| Revenue | $1,242,852,000.00 | ★ $7,287,000,000.00 |
| Revenue This Year | $34.83 | $27.27 |
| Revenue Next Year | $24.84 | $2.85 |
| P/E Ratio | $13.14 | ★ $12.37 |
| Revenue Growth | ★ 31.19 | 1.07 |
| 52 Week Low | $46.26 | $26.73 |
| 52 Week High | $79.50 | $39.59 |
| Indicator | HALO | UGI |
|---|---|---|
| Relative Strength Index (RSI) | 34.09 | 65.13 |
| Support Level | $61.23 | $37.28 |
| Resistance Level | $63.26 | $38.15 |
| Average True Range (ATR) | 2.42 | 0.80 |
| MACD | -0.79 | -0.13 |
| Stochastic Oscillator | 7.60 | 41.43 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.